Trials / Completed
CompletedNCT06499012
The Efficacy of Nutrilite All-plant Protein Booster to Improve Sarcopenia and Osteoarthritis in Middle-aged and Elderly People
A Randomized, Double-blind Clinical Study of the Efficacy of Nutrilite All-plant Protein Booster to Improve Sarcopenia and Osteoarthritis in Middle-aged and Elderly People
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 139 (actual)
- Sponsor
- Amway (China) R&D Center · Industry
- Sex
- All
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to learn whether Amway Nutrilite All-plant protein booster prototype product (test product) will improve sarcopenia (SA) and osteoarthritis (OA) in middle-aged and elderly people. It will also learn about the improvement of Quality of life (QoL) in them. The main questions it aims to answer are: * Does the test product will improve the SA in terms of Short Physical Performance Battery (SPPB score) after 12 weeks' intervention? * Does the test product will improve the OA in terms of Western Ontario and McMaster Universities Arthritis (WOMAC Index) after 12 weeks' intervention? Researchers will compare Amway All-plant protein booster prototype product to a placebo (a look-alike substance that contains no similar active nutrient ingredients) to see if the test product works to improve SA and OA. Participants will: * Take the test product or a placebo 2 spoons (15g) twice per day for 12 weeks * Visit the site on the baseline day and the 84th day (end day of 12 weeks) for checkups and tests
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | All-plant Protein Booster Product Group | Participants in this arm will take 2 spoons (15g) twice per day for 12 weeks |
| DIETARY_SUPPLEMENT | Placebo Group | Participants in this arm will take 2 spoons (15g) twice per day for 12 weeks |
Timeline
- Start date
- 2025-07-08
- Primary completion
- 2025-10-02
- Completion
- 2025-10-02
- First posted
- 2024-07-12
- Last updated
- 2025-11-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06499012. Inclusion in this directory is not an endorsement.